09/28/2018 / By Edsel Cook
Côte d’Ivoire researchers tested cherry mahogany (Tieghemella heckelii) for its antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). They reported that extracts from the stem bark of the African medicinal plant were able to inhibit the growth of different strains of the drug-resistant pathogenic microbe.
The study was supported by the Institut Pasteur Côte d’Ivoire. Its findings were published in the journal BMC Complementary and Alternative Medicine.
The results of the experiment validated the medicinal value of the cherry mahogany in Côte d’Ivoire ethnomedicine. It also identified the stem bark of the plant as a potential source of new antibacterials that will work on drug-resistant strains of pathogenic bacteria like MRSA.
For the full text of the study, you can visit this page.
To learn more about the antimicrobial potential of cherry mahogany, visit Herbs.news.
Journal Reference:
Kipre BG, Guessennd N, Koné M, Gbonon V, Coulibaly JK, Dosso M. ANTIBACTERIAL ACTIVITY OF THE STEM BARK OF TIEGHEMELLA HECKELII PIERRE EX. A CHEV AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS. BMC Complementary and Alternative Medicine. 2017;17(1). DOI: 10.1186/s12906-017-1681-8.
Tagged Under: African herb, antibacterial, antibiotic resistance, Antibiotics, antimicrobials, bactericidal, cherry mahogany, herbal medicines, methicillin, Methicillin-resistant Staphylococcus aureus, mrsa, natural cures, natural remedies, Staphylococcus aureus